Trial Profile

Evaluation of the Risk of Atrophic Acne Scar Formation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Trifarotene (Primary)
Indications Acne vulgaris
Focus Therapeutic Use
Acronyms START
Sponsors Galderma Research & Development

Most Recent Events

28 Feb 2024 According to Galderma media release, results from this study will be at the American Academy of Dermatology (AAD) Annual Meeting from March 8-12, 2024.
28 Feb 2024 Results published in the Galderma Media Release
15 Oct 2023 Results published in the Dermatology and Therapy.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com